The immunology of atherosclerosis (original) (raw)

• Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128 (2012).
  Article PubMed Google Scholar
• Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).
  Article CAS PubMed Google Scholar
• Schiffrin, E. L., Lipman, M. L. & Mann, J. F. Chronic kidney disease: effects on the cardiovascular system. Circulation 116, 85–97 (2007).
  Article PubMed Google Scholar
• Hakeem, A., Bhatti, S. & Chang, S. M. Screening and risk stratification of coronary artery disease in end-stage renal disease. JACC Cardiovasc. Imaging 7, 715–728 (2014).
  Article PubMed Google Scholar
• Stenvinkel, P. et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 55, 1899–1911 (1999).
  Article CAS PubMed Google Scholar
• Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).
  Article CAS PubMed Google Scholar
• Skalen, K. et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417, 750–754 (2002).
  Article CAS PubMed Google Scholar
• Williams, K. J. & Tabas, I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15, 551–561 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Libby, P., Ridker, P. M. & Hansson, G. K. Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317–325 (2011).
  Article CAS PubMed Google Scholar
• Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat. Immunol. 12, 204–212 (2011).
  Article CAS PubMed Google Scholar
• Stemme, S. et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl Acad. Sci. USA 92, 3893–3897 (1995). Discovery of the cellular immune response in the atherosclerotic plaque.
  Article CAS PubMed PubMed Central Google Scholar
• Frostegard, J. et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145, 33–43 (1999). Study demonstrating that atherosclerosis is a T H 1-type disease.
  Article CAS PubMed Google Scholar
• Virchow, R. in Gesammelte Abhandlungen zur Wissenschaftlichen Medicin (Meidinger & Sohn Corp, 1856).
  Google Scholar
• Anitschkoff, N. Über Veränderungen der Kaninchen-Aorta bei experimentelle Cholesterolinsteatose. Beitr. Path. Anat. 56, 379–391 (in German) (1913).
  Google Scholar
• de Beer, F. C. et al. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br. Heart J. 47, 239–243 (1982).
  Article CAS PubMed PubMed Central Google Scholar
• Liuzzo, G. et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med. 331, 417–424 (1994). Study demonstrating that CRP is a biomarker for cardiovascular disease.
  Article CAS PubMed Google Scholar
• Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336, 973–979 (1997).
  Article CAS PubMed Google Scholar
• Hirschfield, G. M. et al. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc. Natl Acad. Sci. USA 102, 8309–8314 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Tennent, G. A. et al. Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− mice. Atherosclerosis 196, 248–255 (2008).
  Article CAS PubMed Google Scholar
• Morrone, G. et al. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes. J. Biol. Chem. 263, 12554–12558 (1988).
  CAS PubMed Google Scholar
• Hoefer, I. E. et al. Novel methodologies for biomarker discovery in atherosclerosis. Eur. Heart J. 36, 2635–2642 (2015).
  Article CAS PubMed Google Scholar
• Ridker, P. M. et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008). Report that patients with elevated CRP levels benefit from statin therapy.
  Article CAS PubMed Google Scholar
• Qureshi, A. R. et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J. Am. Soc. Nephrol. 13 (Suppl. 1), S28–S36 (2002).
  PubMed Google Scholar
• Tong, M. et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin. J. Am. Soc. Nephrol. 2, 889–897 (2007).
  Article CAS PubMed Google Scholar
• Norata, G. D., Garlanda, C. & Catapano, A. L. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases. Trends Cardiovasc. Med. 20, 35–40 (2010).
  Article CAS PubMed Google Scholar
• Deban, L. et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat. Immunol. 11, 328–334 (2010).
  Article CAS PubMed Google Scholar
• Norata, G. D. et al. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120, 699–708 (2009).
  Article CAS PubMed Google Scholar
• Muhlestein, J. B. et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97, 633–636 (1998).
  Article CAS PubMed Google Scholar
• Caligiuri, G., Rottenberg, M., Nicoletti, A., Wigzell, H. & Hansson, G. K. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103, 2834–2838 (2001). Study demonstrating that Chlamydia pneumoniae does not cause atherosclerosis.
  Article CAS PubMed Google Scholar
• Wright, S. D. et al. Infectious agents are not necessary for murine atherogenesis. J. Exp. Med. 191, 1437–1442 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Andraws, R., Berger, J. S. & Brown, D. L. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 293, 2641–2647 (2005). Study demonstrating that antibiotics do not prevent myocardial infarction.
  Article CAS PubMed Google Scholar
• Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 (2011). Study linking gut metabolism to cardiovascular disease.
  Article CAS PubMed PubMed Central Google Scholar
• Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333–338 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Harismendy, O. et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 470, 264–268 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lusis, A. J. Genetics of atherosclerosis. Trends Genet. 28, 267–275 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Davies, R. W. et al. A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ. Cardiovasc. Genet. 5, 217–225 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Swanberg, M. et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet. 37, 486–494 (2005).
  Article CAS PubMed Google Scholar
• Bjorkbacka, H. et al. Weak associations between human leucocyte antigen genotype and acute myocardial infarction. J. Intern. Med. 268, 50–58 (2010).
  CAS PubMed Google Scholar
• Pentikainen, M. O., Oorni, K., Ala-Korpela, M. & Kovanen, P. T. Modified LDL — trigger of atherosclerosis and inflammation in the arterial intima. J. Intern. Med. 247, 359–370 (2000).
  Article CAS PubMed Google Scholar
• Cybulsky, M. I. & Gimbrone, M. A. Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791 (1991). Discovery that the leukocyte-recruiting adhesion molecule VCAM-1 is induced during atherogenesis.
  Article CAS PubMed Google Scholar
• Nakashima, Y., Raines, E. W., Plump, A. S., Breslow, J. L. & Ross, R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18, 842–851 (1998).
  Article CAS PubMed Google Scholar
• Chevre, R. et al. High-resolution imaging of intravascular atherogenic inflammation in live mice. Circ. Res. 114, 770–779 (2014).
  Article CAS PubMed Google Scholar
• McArdle, S., Mikulski, Z. & Ley, K. Live cell imaging to understand monocyte, macrophage, and dendritic cell function in atherosclerosis. J. Exp. Med. 213, 1117–1131 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Fowler, S., Shio, H. & Haley, N. J. Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations. Lab. Invest. 41, 372–378 (1979).
  CAS PubMed Google Scholar
• Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19, 1166–1172 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Goldstein, J. L., Ho, Y. K., Basu, S. K. & Brown, M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl Acad. Sci. USA 76, 333–337 (1979). Discovery of scavenger receptor expression on macrophages.
  Article CAS PubMed PubMed Central Google Scholar
• Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709–721 (2013). State-of-the-art review of the role of macrophages in atherosclerosis.
  Article CAS PubMed PubMed Central Google Scholar
• Kunjathoor, V. V. et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277, 49982–49988 (2002).
  Article CAS PubMed Google Scholar
• Buono, C., Anzinger, J. J., Amar, M. & Kruth, H. S. Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions. J. Clin. Invest. 119, 1373–1381 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Park, Y. M., Febbraio, M. & Silverstein, R. L. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119, 136–145 (2009).
  CAS PubMed Google Scholar
• Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166–6173 (2000).
  Article CAS PubMed Google Scholar
• Chinetti-Gbaguidi, G. et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways. Circ. Res. 108, 985–995 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Kadl, A. et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ. Res. 107, 737–746 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014).
  Google Scholar
• Rong, J. X., Shapiro, M., Trogan, E. & Fisher, E. A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl Acad. Sci. USA 100, 13531–13536 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Feil, S. et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ. Res. 115, 662–667 (2014). Evidence for transdifferentiation accounting for foam cells of lesions.
  Article CAS PubMed Google Scholar
• Shankman, L. S. et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat. Med. 21, 628–637 (2015). Further evidence that smooth muscle cells can develop into macrophage-like cells.
  Article CAS PubMed PubMed Central Google Scholar
• Allahverdian, S., Chehroudi, A. C., McManus, B. M., Abraham, T. & Francis, G. A. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 129, 1551–1559 (2014).
  Article CAS PubMed Google Scholar
• Jonasson, L., Holm, J., Skalli, O., Bondjers, G. & Hansson, G. K. Regional accumulations of T-cells, macrophages, and smooth-muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131–138 (1986). Discovery of immune cells in atherosclerosis.
  Article CAS PubMed Google Scholar
• Richardson, P. D., Davies, M. J. & Born, G. V. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2, 941–944 (1989).
  Article CAS PubMed Google Scholar
• Naghavi, M. et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108, 1664–1672 (2003).
  Article PubMed Google Scholar
• van der Wal, A. C., Becker, A. E., van der Loos, C. M. & Das, P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89, 36–44 (1994).
  Article CAS PubMed Google Scholar
• Kubo, T. et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J. Am. Coll. Cardiol. 50, 933–939 (2007).
  Article PubMed Google Scholar
• Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A. & Schwartz, S. M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262–1275 (2000).
  Article CAS PubMed Google Scholar
• Libby, P. & Pasterkamp, G. Requiem for the 'vulnerable plaque'. Eur. Heart J. 36, 2984–2987 (2015). Provocative review on the changing features of acute coronary syndromes.
  PubMed Google Scholar
• van Lammeren, G. W. et al. Time-dependent changes in atherosclerotic plaque composition in patients undergoing carotid surgery. Circulation 129, 2269–2276 (2014).
  Article CAS PubMed Google Scholar
• Amento, E. P., Ehsani, N., Palmer, H. & Libby, P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 11, 1223–1230 (1991).
  Article CAS PubMed Google Scholar
• Ovchinnikova, O. A. et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. J. Intern. Med. 276, 525–536 (2014).
  Article CAS PubMed Google Scholar
• Hansson, G. K., Hellstrand, M., Rymo, L., Rubbia, L. & Gabbiani, G. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J. Exp. Med. 170, 1595–1608 (1989).
  Article CAS PubMed Google Scholar
• Ovchinnikova, O. et al. T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe−/− mice. Am. J. Pathol. 174, 693–700 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Back, M., Ketelhuth, D. F. & Agewall, S. Matrix metalloproteinases in atherothrombosis. Prog. Cardiovasc. Dis. 52, 410–428 (2010).
  Article CAS PubMed Google Scholar
• Kovanen, P. T., Kaartinen, M. & Paavonen, T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92, 1084–1088 (1995).
  Article CAS PubMed Google Scholar
• Ehara, S. et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 110, 3424–3429 (2004).
  Article PubMed Google Scholar
• Edfeldt, K., Swedenborg, J., Hansson, G. K. & Yan, Z. Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105, 1158–1161 (2002). Discovery of Toll-like receptors in human atherosclerosis.
  Article CAS PubMed Google Scholar
• Miller, Y. I. et al. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278, 1561–1568 (2003).
  Article CAS PubMed Google Scholar
• West, X. Z. et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972–976 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lundberg, A. M. & Hansson, G. K. Innate immune signals in atherosclerosis. Clin. Immunol. 134, 5–24 (2010).
  Article CAS PubMed Google Scholar
• Bjorkbacka, H. et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10, 416–421 (2004). Study demonstrating an effect of innate immune activation on atherosclerosis.
  Article CAS PubMed Google Scholar
• Hurt-Camejo, E., Camejo, G., Peilot, H., Oorni, K. & Kovanen, P. Phospholipase A2 in vascular disease. Circ. Res. 89, 298–304 (2001).
  Article CAS PubMed Google Scholar
• Lonn, E. et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293, 1338–1347 (2005).
  Article PubMed Google Scholar
• Mann, J. F. et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease — results of the renal Hope-2 study. Nephrol. Dial. Transplant. 23, 645–653 (2008).
  Article CAS PubMed Google Scholar
• White, H. D. et al. Darapladib for preventing ischemic events in stable coronary heart disease. N. Engl. J. Med. 370, 1702–1711 (2014).
  Article CAS PubMed Google Scholar
• O'Donoghue, M. L. et al. Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. JAMA 312, 1006–1015 (2014).
  Article CAS PubMed Google Scholar
• Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010). Study showing that cholesterol crystals activate the inflammasome in early atherogenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Rajamaki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 5, e11765 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ridker, P. M., Thuren, T., Zalewski, A. & Libby, P. Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am. Heart J. 162, 597–605 (2011).
  Article CAS PubMed Google Scholar
• Loppnow, H. & Libby, P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J. Clin. Invest. 85, 731–738 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Maier, W. et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111, 1355–1361 (2005).
  Article CAS PubMed Google Scholar
• Biasucci, L. M. et al. Elevated levels of interleukin-6 in unstable angina. Circulation 94, 874–877 (1996).
  Article CAS PubMed Google Scholar
• Drechsler, M., Megens, R. T., van Zandvoort, M., Weber, C. & Soehnlein, O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122, 1837–1845 (2010).
  Article CAS PubMed Google Scholar
• Tupin, E. et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199, 417–422 (2004). Study demonstrating a role of lipid-recognizing natural killer T cells in atherosclerosis.
  Article CAS PubMed PubMed Central Google Scholar
• Whitman, S. C., Rateri, D. L., Szilvassy, S. J., Yokoyama, W. & Daugherty, A. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler. Thromb. Vasc. Biol. 24, 1049–1054 (2004).
  Article CAS PubMed Google Scholar
• van Puijvelde, G. H. et al. Effect of natural killer T cell activation on the initiation of atherosclerosis. Thromb. Haemost. 102, 223–230 (2009).
  Article CAS PubMed Google Scholar
• Cheng, H. Y., Wu, R. & Hedrick, C. C. Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis. Atherosclerosis 234, 265–269 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Elhage, R. et al. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am. J. Pathol. 165, 2013–2018 (2004).
  Article PubMed PubMed Central Google Scholar
• Jonasson, L., Holm, J., Skalli, O., Gabbiani, G. & Hansson, G. K. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Invest. 76, 125–131 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Bobryshev, Y. V. & Lord, R. S. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc. Res. 37, 799–810 (1998).
  Article CAS PubMed Google Scholar
• Llodra, J. et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl Acad. Sci. USA 101, 11779–11784 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Palinski, W. et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl Acad. Sci. USA 86, 1372–1376 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Bui, M. N. et al. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Am. Heart J. 131, 663–667 (1996).
  Article CAS PubMed Google Scholar
• Wu, R., Huang, Y. H., Elinder, L. S. & Frostegard, J. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 18, 626–630 (1998).
  Article CAS PubMed Google Scholar
• Shaw, P. X. et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105, 1731–1740 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Fredrikson, G. N. et al. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 23, 872–878 (2003).
  Article CAS PubMed Google Scholar
• Xu, Q., Kleindienst, R., Waitz, W., Dietrich, H. & Wick, G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 91, 2693–2702 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Benagiano, M. et al. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J. Immunol. 174, 6509–6517 (2005).
  Article CAS PubMed Google Scholar
• George, J., Afek, A., Gilburd, B., Shoenfeld, Y. & Harats, D. Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 38, 900–905 (2001).
  Article CAS PubMed Google Scholar
• Schett, G. et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 96, 2569–2577 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Wick, G., Jakic, B., Buszko, M., Wick, M. C. & Grundtman, C. The role of heat shock proteins in atherosclerosis. Nat. Rev. Cardiol. 11, 516–529 (2014).
  Article CAS PubMed Google Scholar
• Maron, R. et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106, 1708–1715 (2002).
  Article CAS PubMed Google Scholar
• Klingenberg, R., Ketelhuth, D. F., Strodthoff, D., Gregori, S. & Hansson, G. K. Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe−/− mice. Immunobiology 217, 540–547 (2012).
  Article CAS PubMed Google Scholar
• George, J. et al. Adoptive transfer of beta2-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102, 1822–1827 (2000).
  Article CAS PubMed Google Scholar
• Duner, P. et al. Immunization of apoE−/− mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Cardiovasc. Res. 91, 528–536 (2011).
  Article CAS PubMed Google Scholar
• Grabner, R. et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice. J. Exp. Med. 206, 233–248 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Martel, C. et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J. Clin. Invest. 123, 1571–1579 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Cuffy, M. C. et al. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege. J. Immunol. 179, 5246–5254 (2007).
  Article CAS PubMed Google Scholar
• Galkina, E. et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203, 1273–1282 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Watanabe, M. et al. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J. Atheroscler. Thromb. 14, 325–331 (2007).
  Article PubMed Google Scholar
• Hu, D. et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin beta receptors. Immunity 42, 1100–1115 (2015). Study describing the formation of tertiary lymphoid organs around atherosclerotic arteries.
  Article CAS PubMed PubMed Central Google Scholar
• Clement, M. et al. Control of the T follicular helper-germinal center B-cell axis by CD8+ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation 131, 560–570 (2015).
  Article CAS PubMed Google Scholar
• Hansson, G. K., Holm, J. & Jonasson, L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135, 169–175 (1989).
  CAS PubMed PubMed Central Google Scholar
• Zhou, X., Stemme, S. & Hansson, G. K. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am. J. Pathol. 149, 359–366 (1996).
  CAS PubMed PubMed Central Google Scholar
• Stemme, S., Holm, J. & Hansson, G. K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 12, 206–211 (1992).
  Article CAS PubMed Google Scholar
• Paulsson, G., Zhou, X., Tornquist, E. & Hansson, G. K. Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20, 10–17 (2000).
  Article CAS PubMed Google Scholar
• Zhou, X., Nicoletti, A., Elhage, R. & Hansson, G. K. Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102, 2919–2922 (2000).
  Article CAS PubMed Google Scholar
• Zhou, X., Robertson, A. K., Hjerpe, C. & Hansson, G. K. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26, 864–870 (2006).
  Article CAS PubMed Google Scholar
• Dansky, H. M., Charlton, S. A., Harper, M. M. & Smith, J. D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl Acad. Sci. USA 94, 4642–4646 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Song, L., Leung, C. & Schindler, C. Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108, 251–259 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Daugherty, A. et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E−/− mice. J. Clin. Invest. 100, 1575–1580 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Emeson, E. E., Shen, M. L., Bell, C. G. & Qureshi, A. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am. J. Pathol. 149, 675–685 (1996).
  CAS PubMed PubMed Central Google Scholar
• Olofsson, P. S. et al. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117, 1292–1301 (2008).
  Article CAS PubMed Google Scholar
• Hermansson, A. et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J. Exp. Med. 207, 1081–1093 (2010). Study showing that T cells recognize ApoB peptides of LDL.
  Article CAS PubMed PubMed Central Google Scholar
• Uyemura, K. et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J. Clin. Invest. 97, 2130–2138 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Gupta, S. et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752–2761 (1997). Study showing that the T H 1 cytokine IFN γ promotes atherosclerosis.
  Article CAS PubMed PubMed Central Google Scholar
• Whitman, S. C., Ravisankar, P. & Daugherty, A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E−/− mice. J. Interferon Cytokine Res. 22, 661–670 (2002).
  Article CAS PubMed Google Scholar
• Buono, C. et al. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23, 454–460 (2003).
  Article CAS PubMed Google Scholar
• Buono, C. et al. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc. Natl Acad. Sci. USA 102, 1596–1601 (2005). Study showing that the T H 1 pathway is proatherogenic.
  Article CAS PubMed PubMed Central Google Scholar
• Pober, J. S. et al. Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J. Exp. Med. 157, 1339–1353 (1983).
  Article CAS PubMed Google Scholar
• Hansson, G. K., Jonasson, L., Holm, J., Clowes, M. M. & Clowes, A. W. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ. Res. 63, 712–719 (1988).
  Article CAS PubMed Google Scholar
• Perisic, L. et al. Gene expression signatures, pathways and networks in carotid atherosclerosis. J. Intern. Med. 279, 293–308 (2016).
  Article CAS PubMed Google Scholar
• Zhou, X., Paulsson, G., Stemme, S. & Hansson, G. K. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101, 1717–1725 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Davenport, P. & Tipping, P. G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol. 163, 1117–1125 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• King, V. L., Szilvassy, S. J. & Daugherty, A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor−/− mice. Arterioscler. Thromb. Vasc. Biol. 22, 456–461 (2002).
  Article CAS PubMed Google Scholar
• Binder, C. J. et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114, 427–437 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Cardilo-Reis, L. et al. Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol. Med. 4, 1072–1086 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Miller, A. M. et al. IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205, 339–346 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• IBC 50K CAD Consortium. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 7, e1002260 (2011).
• Lim, H. et al. Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. Immunity 40, 153–165 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Eid, R. E. et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119, 1424–1432 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• de Boer, O. J. et al. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. J. Pathol. 220, 499–508 (2010).
  CAS PubMed Google Scholar
• Danzaki, K. et al. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 32, 273–280 (2012).
  Article CAS PubMed Google Scholar
• Usui, F. et al. Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice. Biochem. Biophys. Res. Commun. 420, 72–77 (2012).
  Article CAS PubMed Google Scholar
• Madhur, M. S. et al. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 1565–1572 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485–498 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gao, Q. et al. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J. Immunol. 185, 5820–5827 (2010).
  Article CAS PubMed Google Scholar
• Erbel, C. et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J. Immunol. 183, 8167–8175 (2009).
  Article CAS PubMed Google Scholar
• Smith, E. et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121, 1746–1755 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Taleb, S. et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 206, 2067–2077 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cheng, X. et al. Inhibition of IL-17A in atherosclerosis. Atherosclerosis 215, 471–474 (2011).
  Article CAS PubMed Google Scholar
• Gistera, A. et al. Transforming growth factor-beta signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci. Transl Med. 5, 196ra100 (2013). Study of the plaque-stabilizing role of T H 17 cells.
  Article CAS PubMed Google Scholar
• Cheng, X. et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 127, 89–97 (2008).
  Article CAS PubMed Google Scholar
• Simon, T. et al. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur. Heart J. 34, 570–577 (2013).
  Article CAS PubMed Google Scholar
• de Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M. & van der Wal, A. C. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS ONE 2, e779 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Maganto-Garcia, E., Tarrio, M. L., Grabie, N., Bu, D. X. & Lichtman, A. H. Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 124, 185–195 (2011).
  Article PubMed PubMed Central Google Scholar
• Ait-Oufella, H. et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178–180 (2006). Study showing an atheroprotective role of T reg cells.
  Article CAS PubMed Google Scholar
• Klingenberg, R. et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J. Clin. Invest. 123, 1323–1334 (2013). Definitive evidence for an atheroprotective role of FOXP3+ T reg cells.
  Article CAS PubMed PubMed Central Google Scholar
• Mor, A. et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 893–900 (2007).
  Article CAS PubMed Google Scholar
• Dinh, T. N. et al. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation 126, 1256–1266 (2012).
  Article CAS PubMed Google Scholar
• Takeda, M. et al. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler. Thromb. Vasc. Biol. 30, 2495–2503 (2010).
  Article CAS PubMed Google Scholar
• Sasaki, N. et al. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 120, 1996–2005 (2009).
  Article CAS PubMed Google Scholar
• Kita, T. et al. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovasc. Res. 102, 107–117 (2014).
  Article CAS PubMed Google Scholar
• Foks, A. C. et al. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis 218, 53–60 (2011).
  Article CAS PubMed Google Scholar
• Klingenberg, R. et al. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 946–952 (2010). Study showing that mucosal vaccination protects against atherosclerosis.
  Article CAS PubMed Google Scholar
• Wigren, M. et al. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J. Intern. Med. 269, 546–556 (2011).
  Article CAS PubMed Google Scholar
• Herbin, O. et al. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 32, 605–612 (2012).
  Article CAS PubMed Google Scholar
• Mallat, Z. et al. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85, e17–e24 (1999). Discovery of the atheroprotective role of IL-10.
  Article CAS PubMed Google Scholar
• Pinderski Oslund, L. J. et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19, 2847–2853 (1999).
  Article CAS PubMed Google Scholar
• Caligiuri, G. et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9, 10–17 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. & Flavell, R. A. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24, 99–146 (2006).
  Article CAS PubMed Google Scholar
• Robertson, A. K. et al. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J. Clin. Invest. 112, 1342–1350 (2003). Study demonstrating that the immunomodulatory action of TGFβ controls atherosclerosis.
  Article CAS PubMed PubMed Central Google Scholar
• Mallat, Z. et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89, 930–934 (2001).
  Article CAS PubMed Google Scholar
• Lutgens, E. et al. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22, 975–982 (2002).
  Article CAS PubMed Google Scholar
• Frutkin, A. D. et al. TGF-β1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 29, 1251–1257 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Reifenberg, K. et al. Overexpression of TGF-beta1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice. PLoS ONE 7, e40990 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Buday, A. et al. Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE−/− mice. Am. J. Physiol. Heart Circ. Physiol. 299, H386–H395 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X. & Hansson, G. K. Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand. J. Immunol. 50, 25–30 (1999).
  Article CAS PubMed Google Scholar
• Caligiuri, G., Nicoletti, A., Poirier, B. & Hansson, G. K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 745–753 (2002). Discovery of atheroprotective immunity carried by B cells.
  Article CAS PubMed PubMed Central Google Scholar
• Major, A. S., Fazio, S. & Linton, M. F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 22, 1892–1898 (2002).
  Article CAS PubMed Google Scholar
• Robinette, C. D. & Fraumeni, J. F. Jr. Splenectomy and subsequent mortality in veterans of the 1939–1945 war. Lancet 2, 127–129 (1977).
  Article CAS PubMed Google Scholar
• Ait-Oufella, H. et al. B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207, 1579–1587 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kyaw, T. et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J. Immunol. 185, 4410–4419 (2010).
  Article CAS PubMed Google Scholar
• Kerekes, G. et al. Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis. Clin. Rheumatol. 28, 705–710 (2009).
  Article PubMed Google Scholar
• Kyaw, T. et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ. Res. 109, 830–840 (2011).
  Article CAS PubMed Google Scholar
• Binder, C. J. et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9, 736–743 (2003). Report that molecular mimicry with pneumococci is involved in LDL reactivity and atherosclerosis.
  Article CAS PubMed Google Scholar
• Centa, M. et al. Atherosclerosis susceptibility in mice is independent of the V1 immunoglobulin heavy chain gene. Arterioscler. Thromb. Vasc. Biol. 36, 25–36 (2016).
  Article CAS PubMed Google Scholar
• Chang, M. K. et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200, 1359–1370 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Grasset, E. K. et al. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc. Natl Acad. Sci. USA 112, E2030–E2038 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Isomaa, B. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689 (2001).
  Article CAS PubMed Google Scholar
• Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860–867 (2006). Expert review on the role of inflammation in metabolic disorders.
  Article CAS PubMed Google Scholar
• Sammalkorpi, K., Valtonen, V., Kerttula, Y., Nikkila, E. & Taskinen, M. R. Changes in serum lipoprotein pattern induced by acute infections. Metab. Clin. Exp. 37, 859–865 (1988).
  Article CAS PubMed Google Scholar
• Tracey, K. J. et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167, 1211–1227 (1988).
  Article CAS PubMed Google Scholar
• Beutler, B. & Cerami, A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 320, 584–588 (1986). Discovery of TNF as a metabolic cytokine — a pioneering study of immunometabolism.
  Article CAS PubMed Google Scholar
• Khovidhunkit, W. et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45, 1169–1196 (2004).
  Article CAS PubMed Google Scholar
• Bensinger, S. J. et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134, 97–111 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Holmqvist, M. E. et al. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J. Intern. Med. 268, 578–585 (2010). Study demonstrating an increased risk of cardiovascular disease in patients with rheumatoid arthritis.
  Article CAS PubMed Google Scholar
• Kerekes, G. et al. Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis. Ann. NY Acad. Sci. 1173, 814–821 (2009).
  Article PubMed Google Scholar
• Jacobsson, L. T. et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J. Rheumatol. 32, 1213–1218 (2005). Study demonstrating that TNF blockade protects against cardiovascular disease in patients with rheumatoid arthritis.
  CAS PubMed Google Scholar
• Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013). Study demonstrating that gut microbiota control regulatory immunity.
  Article CAS PubMed Google Scholar
• Park, J. et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 8, 80–93 (2015).
  Article CAS PubMed Google Scholar
• Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576–585 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Sommer, F. & Backhed, F. The gut microbiota — masters of host development and physiology. Nat. Rev. Microbiol. 11, 227–238 (2013).
  Article CAS PubMed Google Scholar
• Jonasson, L., Holm, J. & Hansson, G. K. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc. Natl Acad. Sci. USA 85, 2303–2306 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Marx, S. O. & Marks, A. R. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104, 852–855 (2001).
  Article CAS PubMed Google Scholar
• Back, M. & Hansson, G. K. Anti-inflammatory therapies for atherosclerosis. Nat. Rev. Cardiol. 12, 199–211 (2015).
  Article CAS PubMed Google Scholar
• Palinski, W., Miller, E. & Witztum, J. L. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl Acad. Sci. USA 92, 821–825 (1995). First report of protective immunity against atherosclerosis induced by vaccination.
  Article CAS PubMed PubMed Central Google Scholar
• Ameli, S. et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 16, 1074–1079 (1996).
  Article CAS PubMed Google Scholar
• George, J. et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138, 147–152 (1998).
  Article CAS PubMed Google Scholar
• Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A. K. & Hansson, G. K. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 108–114 (2001).
  Article CAS PubMed Google Scholar
• Fredrikson, G. N. et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler. Thromb. Vasc. Biol. 23, 879–884 (2003). Study showing that ApoB vaccination reduces atherosclerosis in mice.
  Article CAS PubMed Google Scholar
• Tse, K. et al. Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100. Front. Immunol. 4, 493 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Gistera, A. et al. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis. J. Intern. Med. 281, 383–397 (2017).
  Article CAS PubMed Google Scholar
• van Puijvelde, G. H. et al. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 114, 1968–1976 (2006).
  Article CAS PubMed Google Scholar
• Hermansson, A. et al. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice. Circulation 123, 1083–1091 (2011). Study of cellular immunotherapy targeting LDL in mice.
  Article CAS PubMed Google Scholar
• Ketelhuth, D. F., Gistera, A., Johansson, D. K. & Hansson, G. K. T cell-based therapies for atherosclerosis. Curr. Pharm. Des. 19, 5850–5858 (2013).
  Article CAS PubMed Google Scholar
• Tsimikas, S. et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48, 425–433 (2007).
  Article CAS PubMed Google Scholar
• Lehrer-Graiwer, J. et al. FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity. JACC Cardiovasc. Imaging 8, 493–494 (2015).
  Article PubMed Google Scholar
• Hartvigsen, K. et al. The role of innate immunity in atherogenesis. J. Lipid Res. 50 (Suppl.), S388–S393 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Shoji, T. et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 148, 171–177 (2000).
  Article CAS PubMed Google Scholar
• Habets, K. L. et al. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc. Res. 85, 622–630 (2010).
  Article CAS PubMed Google Scholar
• Freigang, S., Horkko, S., Miller, E., Witztum, J. L. & Palinski, W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol. 18, 1972–1982 (1998).
  Article CAS PubMed Google Scholar
• Schiopu, A. et al. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation 110, 2047–2052 (2004).
  Article CAS PubMed Google Scholar
• Ketelhuth, D. F. et al. Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation 124, 2433–2443 (2011). Study showing that ApoB activates innate immunity.
  Article CAS PubMed Google Scholar
• Steinberg, D. The LDL modification hypothesis of atherogenesis: an update. J. Lipid Res. 50 (Suppl.), S376–S381 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Dongre, A. R. et al. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31, 1485–1494 (2001).
  Article CAS PubMed Google Scholar